3
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Development of a Bioassay for Anti Tumor Activity of Biological Response Modifiers of the Reticuloendothelial Stimulant Class: Reproducibility of the Bioassay

, , &
Pages 385-396 | Published online: 28 Sep 2008
 

Abstract

Intravenously administered DiLuzio glucan, Wellcome C. parvum, and Glaxo BCG caused dose dependent increases in the tumor cell loss from the lungs of C57BL/6J and DBA/2J mice challenged respectively with intravenous 125IuDR labelled B16 or T 1699 mammary carcinoma cells.

The results were reproducible with respect to the optimal doses and the magnitudes and shapes of the dose response curves.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.